POST-PV MF
Clinical trials for POST-PV MF explained in plain language.
Never miss a new study
Get alerted when new POST-PV MF trials appear
Sign up with your email to follow new studies for POST-PV MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for myelofibrosis patients: new drug combo aims to shrink spleens and ease symptoms
Disease control Recruiting nowThis study tests whether adding navtemadlin to the standard drug ruxolitinib helps people with myelofibrosis who aren't getting enough benefit from ruxolitinib alone. About 600 adults with myelofibrosis will first take ruxolitinib, then those with a poor response will be randomly…
Matched conditions: POST-PV MF
Phase: PHASE3 • Sponsor: Kartos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:03 UTC
-
5,000 patients join Long-Term study to unlock mysteries of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term observation of 5,000 adults with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, insurance data, and patient surveys over at least five years to track symptoms, treatments, and how the disease …
Matched conditions: POST-PV MF
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC